PATHWAYS Clinical Trial Update Released
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPolicySafetyCBDTHCNeurologyMental Health Dr. Caplan’s Take “The PATHWAYS trial represents an…
Peter Vermeul’s Post
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCCBDHempSafetyNeurologyMental Health Why This Matters Clinicians need to understand that cannabis effects…
Symptoms improve for cancer patients after cannabis extract use, study finds – leafie
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchCBDTHCPainAnxietySafety Why This Matters # Clinical SignificanceCancer patients experiencing…
Review Finds Just 31% of Consumer CBD Products Meet Label-Accuracy Standard
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDSafetyIndustryResearchPolicyHempDosing Why This Matters Clinicians prescribing or recommending CBD to patients face a…
The CB2 receptor, key in resistance to trastuzumab – Demócrata
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchCBDNeurologyMental HealthSafetyAging Why This Matters This research identifying CB2 receptor involvement in…
What’s in My Weed?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyCBDTHCHempIndustryDosing Clinical Summary This article examines the results of laboratory testing for…
Ohio Tax Department Amends Adult-Use Cannabis Tax Rules
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchSafetyHempTHCCBD Why This Matters Ohio’s tax amendments directly affect the cost and…
What’s in your weed? Study finds issues with labelling, tracking cannabis
✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyIndustryTHCCBDDosing Why This Matters Clinicians need accurate product labeling and composition data…
7 unexpected takeaways from the newest research on cannabis and brain effects
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthNeurologyTHCCBDSafetyPolicy Clinical Summary Recent research on cannabis and neurobiological…
When Back Pain Becomes Chronic: New Drug and Old-Fashioned Remedies Hold Promise
The standardized cannabis pharmaceutical offers a new regulated option for chronic back pain management. This product provides consistent dosing and quality control compared to herbal cannabis. It represents a promising alternative for patients with…